Literature DB >> 3872424

Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.

R P Friedland, T F Budinger, E Koss, B A Ober.   

Abstract

We performed dynamic positron emission tomographic studies with [18F]fluorodeoxyglucose in 17 subjects with presumed Alzheimer's disease (AD) and 7 healthy aged subjects. Glucose metabolism was depressed by 27% in temporal-parietal cortex of the AD group, as compared to healthy aged controls. This focal impairment in temporal-parietal glucose use was found in all AD subjects. In addition, the AD group showed a striking lateral asymmetry of cortical metabolism not favoring either hemisphere, which has not been previously reported. Relationships between these focal changes and behavioral features of the illness were demonstrated. These results have important implications for the diagnosis and perhaps the etiology of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872424     DOI: 10.1016/0304-3940(85)90543-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 2.  Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.

Authors:  Giovanni Pennisi; Raffaele Ferri; Giuseppe Lanza; Mariagiovanna Cantone; Manuela Pennisi; Valentina Puglisi; Giulia Malaguarnera; Rita Bella
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

3.  The investigation of Alzheimer's disease with single photon emission tomography.

Authors:  A Burns; M P Philpot; D C Costa; P J Ell; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 4.  Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.

Authors:  P L McGeer; H Kamo; R Harrop; D K Li; H Tuokko; E G McGeer; M J Adam; W Ammann; B L Beattie; D B Calne
Journal:  CMAJ       Date:  1986-03-15       Impact factor: 8.262

5.  Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.

Authors:  R F Butterworth; A M Besnard
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

6.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

7.  Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia.

Authors:  K Meguro; C Doi; M Ueda; T Yamaguchi; H Matsui; S Kinomura; M Itoh; K Yamada; H Sasaki
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 8.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

9.  The lateralized smell test for detecting Alzheimer's disease: failure to replicate.

Authors:  Richard L Doty; Edgardo A Bayona; Daniel S Leon-Ariza; Juan Cuadros; Inna Chung; Britney Vazquez; Fidias E Leon-Sarmiento
Journal:  J Neurol Sci       Date:  2014-03-19       Impact factor: 3.181

10.  99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions.

Authors:  G Stoppe; J Staedt; A Kögler; R Schütze; H J Kunert; D Sandrock; D L Munz; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.